219 related articles for article (PubMed ID: 7903383)
21. A common binding site for primary prostanoids in vascular smooth muscles: a definitive discrimination of the binding for thromboxane A2/prostaglandin H2 receptor agonist from its antagonist.
Hanasaki K; Arita H
Biochim Biophys Acta; 1989 Sep; 1013(1):28-35. PubMed ID: 2528990
[TBL] [Abstract][Full Text] [Related]
22. Radioligand binding assays for thromboxane A2/prostaglandin H2 receptors.
Halushka PV; Morinelli TA; Mais DE
Methods Enzymol; 1990; 187():397-405. PubMed ID: 2146462
[No Abstract] [Full Text] [Related]
23. Synthesis and platelet antiaggregatory activity of trimetoquinol analogs as endoperoxide/thromboxane A2 antagonists.
Harrold MW; Gerhardt MA; Romstedt K; Feller DR; Miller DD
Drug Des Deliv; 1987 Feb; 1(3):193-207. PubMed ID: 3509333
[TBL] [Abstract][Full Text] [Related]
24. Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets.
Hedberg A; Hall SE; Ogletree ML; Harris DN; Liu EC
J Pharmacol Exp Ther; 1988 Jun; 245(3):786-92. PubMed ID: 2968449
[TBL] [Abstract][Full Text] [Related]
25. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
Lumley P; White BP; Humphrey PP
Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
[TBL] [Abstract][Full Text] [Related]
26. Biochemical and functional characterization of 1-benzyl substituted trimetoquinol affinity analogs on rat and human beta-adrenoceptors.
Mehta RC; Salazar-Bookaman MM; Fertel RH; De Los Angeles J; Nikulin VI; Fraundorfer PF; Miller DD; Feller DR
Biochem Pharmacol; 2000 Mar; 59(5):517-29. PubMed ID: 10660118
[TBL] [Abstract][Full Text] [Related]
27. Role of thromboxane A2/prostaglandin H2 receptor in the vasoconstrictor response of rat aorta to endothelin.
Reynolds EE; Mok LL
J Pharmacol Exp Ther; 1990 Mar; 252(3):915-21. PubMed ID: 2138670
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
Tymkewycz PM; Jones RL; Wilson NH; Marr CG
Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
[TBL] [Abstract][Full Text] [Related]
29. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
Miki I; Kase H; Ishii A
Eur J Pharmacol; 1992 Oct; 227(2):199-204. PubMed ID: 1426029
[TBL] [Abstract][Full Text] [Related]
30. Characterization of binding of a specific antagonist, [3H]-SQ 29,548, to soluble thromboxane A2/prostaglandin H2 (TP) receptors in human platelet membranes.
Monshizadegan H; Hedberg A; Webb ML
Life Sci; 1992; 51(6):431-7. PubMed ID: 1386132
[TBL] [Abstract][Full Text] [Related]
31. Distinct effects of z-335, a new thromboxane A2 receptor antagonist, on rabbit platelets and aortic smooth muscle.
Yoshida M; Sato Y; Shimura T; Ohkubo S; Honma S; Tanaka T; Kurimoto T; Nakahata N
Pharmacology; 2007; 79(1):50-6. PubMed ID: 17139194
[TBL] [Abstract][Full Text] [Related]
32. Hydroxylated 22-carbon fatty acids in platelet and vascular smooth muscle function: interference with TXA2/PGH2 receptors.
Karanian JW; Salem N
Agents Actions Suppl; 1995; 45():39-45. PubMed ID: 7717199
[TBL] [Abstract][Full Text] [Related]
33. Antagonistic actions of S-145 on vascular and platelet thromboxane A2 receptors.
Mihara S; Hara S; Ueda M; Ide M; Fujimoto M
Eur J Pharmacol; 1989 Nov; 171(2-3):179-87. PubMed ID: 2533558
[TBL] [Abstract][Full Text] [Related]
34. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
[No Abstract] [Full Text] [Related]
35. Specific receptors for thromboxane A2 in cultured vascular smooth muscle cells of rat aorta.
Hanasaki K; Nakano K; Kasai H; Arita H; Ohtani K; Doteuchi M
Biochem Biophys Res Commun; 1988 Feb; 150(3):1170-5. PubMed ID: 2963633
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological properties of novel bicyclic isoquinoline analogs in isolated guinea pig atria, trachea and in human platelets: relationship to trimetoquinol.
Shams G; Fedyna J; Romstedt KJ; Adejare A; Miller DD; Roche VF; Feller DR
Gen Pharmacol; 1991; 22(6):1155-63. PubMed ID: 1687397
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
Krauss AH; Woodward DF; Burk RM; Gac TS; Gibson LL; Protzman CE; Abbass F; Marshall K; Senior J
J Ocul Pharmacol Ther; 1997 Aug; 13(4):303-12. PubMed ID: 9261766
[TBL] [Abstract][Full Text] [Related]
38. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats.
Tang EH; Jensen BL; Skott O; Leung GP; Feletou M; Man RY; Vanhoutte PM
Cardiovasc Res; 2008 Apr; 78(1):130-8. PubMed ID: 18093985
[TBL] [Abstract][Full Text] [Related]
39. Beta-adrenoceptor subtype activities of trimetoquinol derivatives: biochemical studies on human beta-adrenoceptors expressed in chinese hamster ovary cells.
Konkar AA; Vansal SS; Shams G; Fraundorfer PF; Zheng WP; Nikulin VI; De Los Angeles J; Fertel RH; Miller DD; Feller DR
J Pharmacol Exp Ther; 1999 Nov; 291(2):875-83. PubMed ID: 10525112
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist.
Hanson J; Rolin S; Reynaud D; Qiao N; Kelley LP; Reid HM; Valentin F; Tippins J; Kinsella BT; Masereel B; Pace-Asciak C; Pirotte B; Dogné JM
J Pharmacol Exp Ther; 2005 Apr; 313(1):293-301. PubMed ID: 15626721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
